This inventor holds 1 USPTO granted patent. Top assignee: Biophausia Ab (Publ). Active years: 2001.
Company Filing History:
Years Active: 2001
Title: The Innovations of Mats Sjoquist
Introduction
Mats Sjoquist is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of cancer treatment through his innovative approaches to drug delivery systems. His work focuses on enhancing the effectiveness of anti-cancer agents, particularly in solid tumors.
Latest Patents
Mats Sjoquist holds a patent for an invention titled "Enhanced anti-cancer agent delivery to solid tumors by primer compounds." This patent describes primer compositions that facilitate the delivery of anti-cancer agents to solid tumors in mammals, including humans. The primer comprises a pharmaceutically acceptable agent that increases the intracellular levels of cyclic adenosine monophosphate (cAMP) in normal connective tissue cells within solid tumors. By local administration of the primer to the tumor area, interstitial pressure is lowered, improving the delivery of anti-cancer agents.
Career Highlights
Mats Sjoquist is associated with Biophausia AB, a company dedicated to advancing pharmaceutical innovations. His work has been instrumental in developing new methods for cancer treatment, showcasing his commitment to improving patient outcomes through scientific research.
Collaborations
Mats has collaborated with notable colleagues, including Kristofer Rubin and Rolf Reed. Their combined expertise has contributed to the advancement of innovative solutions in the field of oncology.
Conclusion
Mats Sjoquist's contributions to cancer treatment through his innovative patent demonstrate his dedication to improving therapeutic strategies. His work continues to inspire advancements in the medical field, particularly in the delivery of anti-cancer agents.